πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6770273

Vaccine based on attenuated Haemophilus somnus

The Regents of the University of California Β· Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6752993

Abundant extracellular product vaccines and methods for their production and use

The Regents of the University of California Β· Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6734172

Surface receptor antigen vaccines

PACIFIC NORTHWEST RESEARCH INSTITUTE Β· Granted Tue May 11 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713066

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6703016

Apoptotic bodies, monocyte derived cells containing the same, a process for their preparat

I.D.M. Immuno-Designed Molecules Β· Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R5

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6689367

Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleot

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685949

Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis inf

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685948

Replication-defective dengue viruses that are replication-defective in mosquitoes for use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6686190

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6680060

Hepatitus A virus vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673591

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660273

Chimeric vaccine against tick-borne encephalitis virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6638514

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632640

Vaccine against Staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6610295

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines,

Cogent Partners, LP Β· Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6607725

Conjugate vaccine for nontypeable Haemophilus influenzae

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6605282

Multi-subtype FIV vaccines

The Regents of the University of California Β· Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6605460

Avian pneumovirus vaccine

Regents of the University of Minnesota Β· Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired